Reach Us +441474556909
Oxidative stress in Down Syndrome | OMICS International | Abstract
ISSN: 2157-7412

Journal of Genetic Syndromes & Gene Therapy
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Oxidative stress in Down Syndrome

Zafrilla P1, Cerda B1, Soler A1, Xandri JM2, Martinez-Cachá A1 and Mulero J1*

1Department of Food Technology and Nutrition, Catholic University of San Antonio, Murcia 30107, Spain

2University Hospital Virgen de la Arrixaca, Murcia, Spain

*Corresponding Author:
Mulero J
Department of Food Technology and Nutrition
Catholic University of San Antonio, Murcia 30107, Spain
Tel: +34968278751
E-mail: [email protected]

Received date: May 28, 2014; Accepted date:July 14, 2014; Published date: July 30, 2014

Citation: Zafrilla P, Cerda B, Soler A, Xandri JM, Mulero J, et al. (2014) Oxidative stress in Down Syndrome. J Genet Syndr Gene Ther 5:232. doi:10.4172/2157-7412.1000232

Copyright: © 2014 Zafrilla P, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Objective: Down syndrome (DS) is the most common genetic cause of mental retardation, and affected individuals are more prone to infections, early senescence, Alzheimer`s disease and other anomalies. One of the principal characteristic of this pathology is the stress oxidative. Individuals with DS have increased susceptibility to oxidative stress. The objective of this study is evaluated the degree of oxidative stress in an adult population.

Methods: 17 individuals with Down syndrome, aged from 16 to 37 years, with a mean age of 24.3 ± 4.3 years, participated in the study. Were analyzed several biochemical parameters (glucose, urea, creatinine, uric acid, total proteins, albumin, total bilirubin, cholesterol, HDL-cholesterol, LDL-cholesterol, triglycerides, glutamic oxalacetic transaminase (GOT), glutamic-piruvic Transaminase (GPT), Alkaline phosphatase, gamma GT, lactate deshidrogenase (LDH), ferritin, saturation transferrin, transferrin, iron, ferritin, vitamin B12 and folic acid); haematological parameters (red blood cells, haemoglobin concentration, haematocrit, mean corpuscular volume, mean corpuscular haemoglobin, mean corpuscular haemoglobin concentration, platelets, mean platelet volume, leucocytes, neutrophils, lymphocytes, monocytes, eosinophils and basophils; selenium and zinc. The oxidation of proteins was analyzed by measuring the carbonyl groups in plasma; furthermore, it has measured the total antioxidant activity in plasma.

Results: There was statistically significant difference (p<0.05) between the values total antioxidant activity of individuals with DS (1.08 ± 0.18 mM Trolox/L) and control groups (0.84 ± 0.15 mM Trolox/L). The levels of protein carbonyls in individuals with DS (0.51 ± 0.09 nM/ mg protein) were significant higher than the levels of protein carbonyls in control groups (0.34 ± 0.03 nM/ mg protein).

Conclusions: These results provide direct evidence that the oxidative stress is increased in individuals with DS. Since oxidative protein damage reflects increased degenerative processes, this data agrees with the reported premature aging, the increased incidence of cataracts and early Alzheimer changes in DS. This opens the possibility that antioxidant nutrient supplementation might help to ameliorate the pathology of DS.